Decision Support: Building a clinical rules engine with the human touch

I began my career in a clinical laboratory that provided automated interpretations as part of our specialty test results based on clinical guidelines. We learned that many physicians' questions could be answered preemptively through these laboratory insights. For example, test results could include clinical information to help manage patients with kidney stones, offering insights on causes and potential treatments options. After Labcorp acquired that laboratory, we began looking for ways to expand and enhance this program.

Labcorp receives Emergency Use Authorization for at-home collection kit for combined COVID-19 and flu detection

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 1, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined home collection kit that detects COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age. The kit will be available at no upfront cost to those who meet clinical guidelines, which may include experiencing symptoms, being exposed to someone with COVID-19 or if asked to be tested by a health care provider.

Data vs. Insights: Meeting Clinicians and Patients at the Point of Care

Throughout the past decade, I have focused on developing clinical content and decision support tools to help clinicians identify high-risk patients and deliver guideline-based care, with an emphasis on managing complex chronic diseases, including chronic kidney disease (CKD), cardiovascular disease and diabetes. Laboratory results are critical for diagnosing and monitoring a patient's condition, but my experiences in practice and in talking with other clinicians underscore the need for laboratory insights that offer a clearer picture of a patient's health. There is also a need for corresponding information that enhances patient understanding of laboratory test results to increase engagement and compliance with treatment plans. 

Walgreens to make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit available over-the-counter at stores nationwide

DEERFIELD, Ill. & BURLINGTON, N.C., February 24, 2021 - As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Labcorp™ to sell Pixel by Labcorp COVID-19 PCR Test Home Collection Kits over-the-counter in up to 6,000 Walgreens stores nationwide beginning in spring of this year. Walgreens is making significant strides to increase on-site testing capacity at more than 5,000 Walgreens pharmacy locations by April 1, with more than half of sites located in socially vulnerable areas.

Walgreens and Labcorp make Pixel by Labcorp™ at-home COVID-19 collection kit available through Walgreens Find Care®

DEERFIELD, Ill. & BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 21, 2020-- Labcorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, and Walgreens today announced that the Pixel by Labcorp™ At-Home COVID-19 Collection Kit is now available from Labcorp through Walgreens Find Care®, a digital health platform available on the Walgreens app and Walgreens.com. Walgreens currently offers COVID-19 testing in more than 1,100 drive-thru locations across the country.

Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access

Differentiated approach may improve detection methods and inform vaccine discovery for COVID-19 Other industry leaders including LabCorp, through its Covance drug development business, Illumina, and Providence join forces to accelerate this critical effort SEATTLE and REDMOND, Wash.